Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian B Haines

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Cell Cycle (Georgetown, Tex.)|May 12, 2006
Recombination activating genes (RAG) in lymphoma developmentBrian B Haines, Chun Jeih Ryu, Jianzhu Chen
Transgenic Research|August 23, 2018
Identification of the transgenic integration site in 2C T cell receptor transgenic miceChae-Yeon Son, Brian B Haines, Andreas Luch, et al.
RNA (New York, N.Y.)|June 29, 2002
Gene silencing using micro-RNA designed hairpinsMichael T McManus, Christian P Petersen, Brian B Haines, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
Small interfering RNA-mediated gene silencing in T lymphocytesMichael T McManus, Brian B Haines, Christopher P Dillon, et al.
BMC Cancer|October 22, 2016
Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancerMarc A Becker, Xiaonan Hou, Piyawan Tienchaianada, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2003
The T cell receptor beta enhancer promotes access and pairing of Dbeta and Jbeta gene segments during V(D)J recombinationChun Jeih Ryu, Brian B Haines, Dobrin D Draganov, et al.
Molecular and Cellular Biology|July 30, 2004
The T-cell receptor beta variable gene promoter is required for efficient V beta rearrangement but not allelic exclusionChun Jeih Ryu, Brian B Haines, Hye Ran Lee, et al.
Neoplasia (New York, N.Y.)|December 25, 2008
A quantitative volumetric micro-computed tomography method to analyze lung tumors in genetically engineered mouse modelsBrian B Haines, Kimberly A Bettano, Melissa Chenard, et al.
Biochemistry|January 24, 2014
Divergent kinetics differentiate the mechanism of action of two HDAC inhibitorsAstrid M Kral, Nicole Ozerova, Joshua Close, et al.
Cancer Cell|February 14, 2006
Block of T cell development in P53-deficient mice accelerates development of lymphomas with characteristic RAG-dependent cytogenetic alterationsBrian B Haines, Chun Jeih Ryu, Sandy Chang, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cell Cycle (Georgetown, Tex.)|May 12, 2006
Recombination activating genes (RAG) in lymphoma developmentBrian B Haines, Chun Jeih Ryu, Jianzhu Chen
Transgenic Research|August 23, 2018
Identification of the transgenic integration site in 2C T cell receptor transgenic miceChae-Yeon Son, Brian B Haines, Andreas Luch, et al.
RNA (New York, N.Y.)|June 29, 2002
Gene silencing using micro-RNA designed hairpinsMichael T McManus, Christian P Petersen, Brian B Haines, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
Small interfering RNA-mediated gene silencing in T lymphocytesMichael T McManus, Brian B Haines, Christopher P Dillon, et al.
BMC Cancer|October 22, 2016
Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancerMarc A Becker, Xiaonan Hou, Piyawan Tienchaianada, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2003
The T cell receptor beta enhancer promotes access and pairing of Dbeta and Jbeta gene segments during V(D)J recombinationChun Jeih Ryu, Brian B Haines, Dobrin D Draganov, et al.
Molecular and Cellular Biology|July 30, 2004
The T-cell receptor beta variable gene promoter is required for efficient V beta rearrangement but not allelic exclusionChun Jeih Ryu, Brian B Haines, Hye Ran Lee, et al.
Neoplasia (New York, N.Y.)|December 25, 2008
A quantitative volumetric micro-computed tomography method to analyze lung tumors in genetically engineered mouse modelsBrian B Haines, Kimberly A Bettano, Melissa Chenard, et al.
Biochemistry|January 24, 2014
Divergent kinetics differentiate the mechanism of action of two HDAC inhibitorsAstrid M Kral, Nicole Ozerova, Joshua Close, et al.
Cancer Cell|February 14, 2006
Block of T cell development in P53-deficient mice accelerates development of lymphomas with characteristic RAG-dependent cytogenetic alterationsBrian B Haines, Chun Jeih Ryu, Sandy Chang, et al.
Pageof 3